[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Valneva Se ADR (VALN)

Valneva Se ADR (VALN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,338
  • Shares Outstanding, K 86,107
  • Annual Sales, $ 197,610 K
  • Annual Income, $ -130,330 K
  • EBIT $ -6 M
  • EBITDA $ -68 M
  • 60-Month Beta 1.72
  • Price/Sales 2.42
  • Price/Cash Flow N/A
  • Price/Book 3.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.21
  • Number of Estimates 1
  • High Estimate $-0.21
  • Low Estimate $-0.21
  • Prior Year $-0.13
  • Growth Rate Est. (year over year) -61.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.06 +10.47%
on 05/04/26
6.42 -12.93%
on 04/14/26
-0.66 (-10.56%)
since 04/08/26
3-Month
5.06 +10.47%
on 05/04/26
12.18 -54.11%
on 02/24/26
-3.90 (-41.10%)
since 02/06/26
52-Week
5.06 +10.47%
on 05/04/26
12.25 -54.37%
on 08/19/25
-0.79 (-12.38%)
since 05/08/25

Most Recent Stories

More News
Natural Phenomenon or Manufactured Catalyst? The Truth About the 2026 Tick Explosion and Pfizer’s New Vaccine

The spring of 2026 arrived with a vibrant bloom of flowers and an unprecedented, crawling wave of arachnids. Recent social media feeds resemble scenes from a horror movie, a shared experience for millions...

VALN : 5.59 (+0.54%)
PFE : 25.68 (-1.42%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN).  Such investors are advised to contact...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN).  Such investors are advised to...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 5.59 (+0.54%)
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above The investigational...

VALN : 5.59 (+0.54%)
PFE : 25.68 (-1.42%)
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program

VIENNA, Austria , March 18, 2026 /PRNewswire/ -- Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE (" Valneva " or the "Company") ( NASDAQ : VALN ). Such...

VALN : 5.59 (+0.54%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact...

VALN : 5.59 (+0.54%)

Business Summary

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

See More

Key Turning Points

3rd Resistance Point 5.75
2nd Resistance Point 5.70
1st Resistance Point 5.64
Last Price 5.59
1st Support Level 5.53
2nd Support Level 5.48
3rd Support Level 5.42

See More

52-Week High 12.25
Fibonacci 61.8% 9.50
Fibonacci 50% 8.65
Fibonacci 38.2% 7.81
Last Price 5.59
52-Week Low 5.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.